Clarify Health Welcomes Kara Dennis
Today we announced the launch of our Life Sciences division and Kara Dennis joining the team as SVP and GM. Kara will be spearheading this new area of focus, leading the development of new product offerings for biopharmaceutical companies.
This new division will focus on leveraging the AI-driven analytics platform and comprehensive data assets of Clarify to provide scalable insight into patient journeys, clinical trial design, and real world evidence.
Kara joins us after leading mobile health at Medidata Solutions, where she was responsible for the creation of a comprehensive offering in mobile health. While there, she led an experienced team to create, deliver and scale the offering, which included technologies for patent engagement and for the integration of wearable sensor data into clinical trials. Prior to Medidata, Kara spent four years in McKinsey & Co’s healthcare practice, and subsequently worked in corporate development for Ikaria, a private-equity backed biotech since acquired by Mallinckrodt.
“I am thrilled to join Clarify Health to build solutions for capturing and surfacing real world evidence across siloed stakeholders,” said Dennis. “For many years, I have been excited about how we can apply data to impact patient care in a positive and holistic way; the Clarify platform is a powerhouse for providing the life science industry with insights that could transform current approaches to personalized medicine and clinical trials.”
To learn more about this news, read the full announcement here.